Katalysen Ventures AB

Report for the Second Quarter 2022 in Katalysen Ventures

Tue, Aug 09, 2022 15:30 CET

Summary of report below. Full report attached and available under Investor Relations on Katalysen.com. All currencies in SEK unless otherwise specified.A. VENTURE DEVELOPMENT KPIs (LAST PERIOD WITHIN BRACKETS): · New client agreements during the period: 3 (4) · Active clients at the end of the period: 13 (11) · Total calculated market value of Katalysen’s portfolio (shares, options, and convertibles) at the end of the period: 209.2 MSEK (195 MSEK) · Quarterly portfolio growth (shares and options) excluding new cash invested during the period: 0.4% (5.6%) · Value added to

ANNOUNCING PARTNERSHIP AS VENTURE DEVELOPER TO MED4CAST TO PROMOTE THE USE OF AI IN MEDICAL DIAGNOSTICS

Tue, Mar 29, 2022 13:43 CET

Katalysen Ventures is pleased to announce that we have formed a partnership as a venture developer to Swiss digital medtech startup Med4Cast. As a venture developer, Katalysen Ventures has been invited to participate as a co-founder and to invest approximately €12’000 (CHF12’500) at par value. This investment has now been completed, and Katalysen Ventures now owns 20% of Med4cast as a result.Katalysen has been working for more than a year with leading medical, imaging and artificial intelligence experts on developing technology for advanced, machine based, diagnostics in orthopaedics. Given

Report for the Second Quarter 2022 in Katalysen Ventures

ANNOUNCING PARTNERSHIP AS VENTURE DEVELOPER TO MED4CAST TO PROMOTE THE USE OF AI IN MEDICAL DIAGNOSTICS

Subscribe

Media

Share

Report for the Second Quarter 2022 in Katalysen Ventures

ANNOUNCING PARTNERSHIP AS VENTURE DEVELOPER TO MED4CAST TO PROMOTE THE USE OF AI IN MEDICAL DIAGNOSTICS

Subscribe

Media